285 related articles for article (PubMed ID: 20473306)
21. Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.
Onuta G; Rienstra H; de Boer JF; Boer MW; Roks AJ; Klatter FA; Uges DR; Navis G; Rozing J; Hillebrands JL
Transplantation; 2007 Aug; 84(4):517-26. PubMed ID: 17713437
[TBL] [Abstract][Full Text] [Related]
22. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
23. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
[TBL] [Abstract][Full Text] [Related]
24. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes.
Joffre O; Santolaria T; Calise D; Al Saati T; Hudrisier D; Romagnoli P; van Meerwijk JP
Nat Med; 2008 Jan; 14(1):88-92. PubMed ID: 18066074
[TBL] [Abstract][Full Text] [Related]
25. Immunologic basis of transplant-associated arteriosclerosis.
Shi C; Lee WS; He Q; Zhang D; Fletcher DL; Newell JB; Haber E
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4051-6. PubMed ID: 8633015
[TBL] [Abstract][Full Text] [Related]
26. Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients.
Schmidt-Lucke C; Aicher A; Romagnani P; Gareis B; Romagnani S; Zeiher AM; Dimmeler S
Am J Physiol Heart Circ Physiol; 2007 May; 292(5):H2425-31. PubMed ID: 17237241
[TBL] [Abstract][Full Text] [Related]
27. Low-Dose Interleukin-2 Combined With Rapamycin Led to an Expansion of CD4
Hu M; Hawthorne WJ; Nicholson L; Burns H; Qian YW; Liuwantara D; Jimenez Vera E; Chew YV; Williams L; Yi S; Keung K; Watson D; Rogers N; Alexander SI; O'Connell PJ
Diabetes; 2020 Aug; 69(8):1735-1748. PubMed ID: 32381646
[TBL] [Abstract][Full Text] [Related]
28. Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients.
Xufré C; Costa M; Roura-Mir C; Codina-Busqueta E; Usero L; Pizarro E; Obiols G; Jaraquemada D; Martí M
Int Immunol; 2013 Oct; 25(10):563-74. PubMed ID: 23929911
[TBL] [Abstract][Full Text] [Related]
29. Ablation of interferon regulatory factor 4 in T cells induces "memory" of transplant tolerance that is irreversible by immune checkpoint blockade.
Zhang H; Wu J; Zou D; Xiao X; Yan H; Li XC; Chen W
Am J Transplant; 2019 Mar; 19(3):884-893. PubMed ID: 30468559
[TBL] [Abstract][Full Text] [Related]
30. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
Sewgobind VD; Kho MM; van der Laan LJ; Hendrikx TK; van Dam T; Tilanus HW; IJzermans JN; Weimar W; Baan CC
Nephrol Dial Transplant; 2009 May; 24(5):1635-44. PubMed ID: 19176684
[TBL] [Abstract][Full Text] [Related]
31. IL-2-dependent adaptive control of NK cell homeostasis.
Gasteiger G; Hemmers S; Bos PD; Sun JC; Rudensky AY
J Exp Med; 2013 Jun; 210(6):1179-87. PubMed ID: 23650439
[TBL] [Abstract][Full Text] [Related]
32. Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells.
Guo H; Zhang H; Lu L; Ezzelarab MB; Thomson AW
Cell Immunol; 2015 May; 295(1):19-28. PubMed ID: 25732601
[TBL] [Abstract][Full Text] [Related]
33. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
Spriewald BM; Ensminger SM; Bushell A; Wood KJ
Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
[TBL] [Abstract][Full Text] [Related]
34. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation.
Tahvildari M; Omoto M; Chen Y; Emami-Naeini P; Inomata T; Dohlman TH; Kaye AE; Chauhan SK; Dana R
Transplantation; 2016 Mar; 100(3):525-32. PubMed ID: 26881788
[TBL] [Abstract][Full Text] [Related]
35. Human CD4+CD25(high)CD127 (low/neg) regulatory T cells.
Su H; Longhi MS; Wang P; Vergani D; Ma Y
Methods Mol Biol; 2012; 806():287-99. PubMed ID: 22057460
[TBL] [Abstract][Full Text] [Related]
36. Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3.
Ensminger SM; Helm SN; Ohl L; Spriewald BM; Abele S; Wollin M; Wood KJ; Weyand M; Förster R
Transplantation; 2008 Aug; 86(4):590-600. PubMed ID: 18724230
[TBL] [Abstract][Full Text] [Related]
37. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
[TBL] [Abstract][Full Text] [Related]
38. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
[TBL] [Abstract][Full Text] [Related]
39. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells.
Pandiyan P; Zheng L; Ishihara S; Reed J; Lenardo MJ
Nat Immunol; 2007 Dec; 8(12):1353-62. PubMed ID: 17982458
[TBL] [Abstract][Full Text] [Related]
40. Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell-Dependent Mechanisms.
Magee CN; Murakami N; Borges TJ; Shimizu T; Safa K; Ohori S; Cai S; Uffing A; Azzi J; Elyaman W; Charbonnier LM; Liu K; Toprak D; Visner G; Chatila TA; Siebel CW; Najafian N; Riella LV
Circulation; 2019 Sep; 140(10):846-863. PubMed ID: 31266349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
